• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌内脂肪浸润预测肝移植患者围手术期不良结局。

Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation.

机构信息

Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.

出版信息

Am J Transplant. 2020 Feb;20(2):493-503. doi: 10.1111/ajt.15577. Epub 2019 Sep 18.

DOI:10.1111/ajt.15577
PMID:31448486
Abstract

Muscle wasting and alterations of body composition are linked to clinical outcomes in numerous medical conditions. The role of myosteatosis in posttransplant outcomes remains to be determined. Here we investigated skeletal muscle mass and myosteatosis as prognostic factors in patients undergoing orthotopic liver transplantation (OLT). The data of 225 consecutive OLT recipients from a prospective database were retrospectively analyzed (May 2010-December 2017). Computed tomography-based skeletal-muscle-index (muscle mass), visceral-fat-area (visceral adiposity), and mean skeletal-muscle-radiation-attenuation (myosteatosis) were calculated using a segmentation tool. Cut-off values of myosteatosis resulted in a good stratification of patients into low- and high-risk groups in terms of morbidity (Clavien-Dindo ≥3b). Patients with myosteatosis had significantly higher complication rates (90-day Comprehensive Complication Index 68 ± 32 vs 44 ± 30, P < .001) and also displayed significantly longer intensive care (18 ± 25 vs 11 ± 21 days, P < .001) and hospital stay (56 ± 55 vs 33 ± 24 days, P < .001). Estimated costs were 44% higher compared to patients without myosteatosis. Multivariable analysis identified myosteatosis as an independent prognostic factor for major morbidity (odds ratio: 2.772, confidence interval: 1.516-5.066, P = .001). Adding myosteatosis to the well-established Balance-of-Risk-(BAR) score resulted in an increased prognostic value compared to the original BAR score. Myosteatosis may be a useful parameter to predict perioperative outcome in patients undergoing OLT, supporting the role of muscle quality (myosteatosis) over quantity (muscle mass) in this setting.

摘要

肌肉减少和身体成分改变与许多医学病症的临床结果有关。脂肪浸润在移植后结果中的作用仍有待确定。在这里,我们研究了肌肉质量和脂肪浸润作为接受原位肝移植(OLT)患者的预后因素。回顾性分析了 2010 年 5 月至 2017 年 12 月期间从一个前瞻性数据库中连续 225 例 OLT 受者的数据。使用分割工具基于计算机断层扫描计算骨骼肌指数(肌肉质量)、内脏脂肪面积(内脏肥胖)和平均骨骼肌辐射衰减(脂肪浸润)。脂肪浸润的截止值导致患者在发病率方面(Clavien-Dindo ≥3b)分为低风险和高风险组。患有脂肪浸润的患者并发症发生率明显较高(90 天综合并发症指数为 68±32 比 44±30,P<.001),且 ICU 时间(18±25 比 11±21 天,P<.001)和住院时间(56±55 比 33±24 天,P<.001)也明显延长。与无脂肪浸润的患者相比,估计费用高出 44%。多变量分析确定脂肪浸润是主要发病率的独立预后因素(比值比:2.772,置信区间:1.516-5.066,P=.001)。将脂肪浸润添加到既定的风险平衡(BAR)评分中,与原始 BAR 评分相比,预后价值增加。脂肪浸润可能是预测 OLT 患者围手术期结果的有用参数,支持肌肉质量(脂肪浸润)而不是数量(肌肉质量)在这种情况下的作用。

相似文献

1
Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation.肌内脂肪浸润预测肝移植患者围手术期不良结局。
Am J Transplant. 2020 Feb;20(2):493-503. doi: 10.1111/ajt.15577. Epub 2019 Sep 18.
2
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation.受者肌肉脂肪变性对尸体供肝肝移植后移植物和患者存活的作用。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):358-367. doi: 10.1002/jcsm.12669. Epub 2021 Feb 1.
3
Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation.各种肌内脂肪浸润选择标准及其在肝移植后短期和长期结局评估中的价值。
Sci Rep. 2021 Jun 28;11(1):13368. doi: 10.1038/s41598-021-92798-5.
4
Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.肥胖症、肌肉减少症和肌内脂肪增多症:对克罗恩病手术治疗临床结局的影响。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1517-1528. doi: 10.1093/ibd/izad225.
5
The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort.肌肉减少症和肌脂肪变性在欧洲队列中肝细胞癌根治性手术后短期和长期预后中的作用
Cancers (Basel). 2022 Jan 30;14(3):720. doi: 10.3390/cancers14030720.
6
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.围手术期体成分异常对劈离式肝移植术后结局的不良影响:一项多中心回顾性队列研究。
Int J Surg. 2024 Jun 1;110(6):3543-3553. doi: 10.1097/JS9.0000000000001303.
7
Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.肌肉脂肪变性是预后的更重要预测指标:对约翰内斯堡(南非)肝移植结局中肌肉脂肪变性、肌肉减少症和肌肉减少性肥胖的影响分析。
Exp Clin Transplant. 2021 Sep;19(9):948-955. doi: 10.6002/ect.2021.0083. Epub 2021 Aug 9.
8
Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation.放射学评估骨骼肌指数和肌内脂肪含量及其对肝移植术后结局的影响。
Radiol Oncol. 2023 Jun 21;57(2):168-177. doi: 10.2478/raon-2023-0025. eCollection 2023 Jun 1.
9
Low Postoperative Platelet Counts Are Associated with Major Morbidity and Inferior Survival in Adult Recipients of Orthotopic Liver Transplantation.术后血小板计数低与成人原位肝移植受者的主要并发症和生存率降低相关。
J Gastrointest Surg. 2020 Sep;24(9):1996-2007. doi: 10.1007/s11605-019-04337-3. Epub 2019 Aug 6.
10
Impact of myopenia and myosteatosis in patients undergoing abdominal surgery for chronic pancreatitis.慢性胰腺炎患者行腹部手术后肌少症和肌脂减少症的影响。
Surgery. 2022 Jul;172(1):310-318. doi: 10.1016/j.surg.2022.01.021. Epub 2022 Mar 1.

引用本文的文献

1
Type II fibre atrophy and nuclear disruption in decompensated cirrhosis.失代偿期肝硬化中的II型纤维萎缩和核破坏。
JHEP Rep. 2025 May 24;7(9):101455. doi: 10.1016/j.jhepr.2025.101455. eCollection 2025 Sep.
2
Perioperative and Oncological Outcome in Patients Undergoing Curative-Intent Liver Resection for Cholangiocarcinoma in the Context of Osteopenia.骨质疏松背景下接受根治性肝切除术治疗胆管癌患者的围手术期及肿瘤学结局
Cancers (Basel). 2025 Jul 1;17(13):2213. doi: 10.3390/cancers17132213.
3
Impact of myosteatosis on outcomes after liver transplantation: a systematic review and meta-analysis.
肌少性肥胖对肝移植术后结局的影响:一项系统评价和荟萃分析
Hepatol Int. 2025 Jun 9. doi: 10.1007/s12072-025-10845-z.
4
Myosteatosis as a New Risk Factor of Surgical Complications in Kidney Transplant Recipients: A Retrospective Study.肌脂肪变性作为肾移植受者手术并发症的新危险因素:一项回顾性研究
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13746. doi: 10.1002/jcsm.13746.
5
Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta-Analysis.肌肉减少症作为肝移植后肝硬化患者生存和并发症的预测指标:一项系统评价和荟萃分析
Clin Transplant. 2025 Feb;39(2):e70088. doi: 10.1111/ctr.70088.
6
Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis.肌肉减少性肥胖与肝移植后总体生存率较差显著相关:一项系统评价和荟萃分析。
Front Nutr. 2024 Dec 16;11:1387602. doi: 10.3389/fnut.2024.1387602. eCollection 2024.
7
Skeletal Muscle P MR Spectroscopy Surpasses CT in Predicting Patient Survival After Liver Transplantation.骨骼肌磷磁共振波谱在预测肝移植患者生存率方面优于CT。
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13635. doi: 10.1002/jcsm.13635. Epub 2024 Nov 23.
8
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.肌脂肪变性和肌肉流失影响男性肝细胞癌患者的肝移植结局。
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2071-2083. doi: 10.1002/jcsm.13554. Epub 2024 Aug 27.
9
Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis.肌脂肪变性对接受根治性手术的结直肠癌患者的预后影响:一项更新的系统评价和荟萃分析
Front Oncol. 2024 Jun 19;14:1388001. doi: 10.3389/fonc.2024.1388001. eCollection 2024.
10
Influence of body fat tissue on outcomes in patients undergoing hepatectomy or liver transplantation: a systematic review and meta-analysis.体脂组织对肝切除或肝移植患者预后的影响:一项系统评价和荟萃分析。
Int J Surg. 2025 Jan 1;111(1):1167-1181. doi: 10.1097/JS9.0000000000001864.